icrf 198 has been researched along with merbarone in 1 studies
Studies (icrf 198) | Trials (icrf 198) | Recent Studies (post-2010) (icrf 198) | Studies (merbarone) | Trials (merbarone) | Recent Studies (post-2010) (merbarone) |
---|---|---|---|---|---|
24 | 0 | 4 | 74 | 11 | 16 |
Protein | Taxonomy | icrf 198 (IC50) | merbarone (IC50) |
---|---|---|---|
Solute carrier family 22 member 12 | Homo sapiens (human) | 5.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allan, WP; Creighton, AM; Fattman, CL; Hasinoff, BB; Kuschak, TI; Thampatty, P; Yalowich, JC | 1 |
1 other study(ies) available for icrf 198 and merbarone
Article | Year |
---|---|
Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II.
Topics: Aclarubicin; Animals; CHO Cells; Cricetinae; DNA Topoisomerases, Type II; Drug Resistance; Ethylenediamines; Etoposide; Glycine; Mutation; Razoxane; Thiobarbiturates; Topoisomerase II Inhibitors; Verapamil | 1997 |